We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 8,002 results
  1. Pseudotyped Virus for Papillomavirus

    Papillomavirus is difficult to culture in vitro, which limits its related research. The development of pseudotyped virus technology provides a...
    Xueling Wu, Jianhui Nie, Youchun Wang in Pseudotyped Viruses
    Chapter 2023
  2. Human Papillomavirus (HPV) Entry Inhibitors

    Chronic or persistent human papillomavirus (HPV) infection is essential for the development of many types of carcinomas, such as cervical carcinoma....
    Chapter 2022
  3. The interplay between human papillomavirus and vaginal microbiota in cervical cancer development

    Over the past few decades, we have grown accustomed to the idea that human papillomavirus can cause tumors. The genetic and environmental factors...

    Kimia Sharifian, Zabihollah Shoja, Somayeh Jalilvand in Virology Journal
    Article Open access 19 April 2023
  4. Epidemiology and genotypes analysis of human papillomavirus infection in Bei**g, China

    Background

    This study aimed to investigate the epidemiology of high-risk human papillomavirus (HPV) in the female population in Bei**g, China, and...

    Jiao Wang, Haotian Li, ... Hongtu Liu in Virology Journal
    Article Open access 16 January 2024
  5. Inter-epitope spacer variation within polytopic L2-based human papillomavirus antigens affects immunogenicity

    The human papillomavirus minor capsid protein L2 is being extensively explored in pre-clinical studies as an attractive vaccine antigen capable of...

    Yueru Zhang, Filipe Colaco Mariz, ... Martin Müller in npj Vaccines
    Article Open access 24 February 2024
  6. Association of prostate cancer with human papillomavirus infections: a case-control study

    Background

    The highly oncogenic human papillomavirus (HPV) is associated with numerous cancer types. While the role of viruses in the development of...

    Shuo-Han Yin, Shiu-Dong Chung, ... Herng-Ching Lin in Prostate Cancer and Prostatic Diseases
    Article 14 December 2023
  7. Prevalence of the human papillomavirus (HPV) types among cervical dysplasia women attending a gynaecological clinic in Sweden

    Background

    Human papillomavirus (HPV) is the main cause of cervical cancer. HPV-vaccines have led to a significant decrease in HPV-infections and...

    Fabricio Romero García, Johanna Norenhag, ... Juan Du in BJC Reports
    Article Open access 22 August 2023
  8. The POU-HD TFs impede the replication efficiency of several human papillomavirus genomes

    Human papillomavirus (HPV) is a double-stranded DNA virus that infects cutaneous and mucosal epithelial cells. HPV replication initiates at the...

    Martin Kala, Sofiya Babok, ... Alla Piirsoo in Virology Journal
    Article Open access 05 March 2024
  9. Association of SIRT1, CDKN2A, TP73 Genes Polymorphisms with the Risk of Viral Load Increase in Women Infected with Human Papillomavirus

    Abstract

    A high concentration of human papillomavirus (HPV) is one of the main etiological causes of cervical cancer. The formation of a clinically...

    E. V. Mashkina, E. S. Muzlaeva, ... E. G. Derevyanchuk in Russian Journal of Genetics
    Article 01 December 2023
  10. Distribution patterns of human papillomavirus genotypes among women in Guangzhou, China

    Background

    Cervical cancer is associated with high‐risk human papillomavirus (HR-HPV) infection in the world. We aimed to evaluate the status of HPV...

    Shu Li, Kelan Zhang, ... Fei Gao in Infectious Agents and Cancer
    Article Open access 31 October 2023
  11. Genome, HLA and polygenic risk score analyses for prevalent and persistent cervical human papillomavirus (HPV) infections

    Genetic variants that underlie susceptibility to cervical high-risk human papillomavirus (hrHPV) infections are largely unknown. We conducted...

    Sally N. Adebamowo, Adebowale Adeyemo, ... Clement A. Adebamowo in European Journal of Human Genetics
    Article Open access 10 January 2024
  12. Biplex quantitative PCR to detect transcriptionally active human papillomavirus 16 from patient saliva

    Head and neck cancers, particularly oropharyngeal cancers (OPC), have been increasingly associated with human papillomavirus (HPV) infections,...

    Fiona Deutsch, Dayna Sais, ... Nham Tran in BMC Cancer
    Article Open access 10 April 2024
  13. Human papillomavirus spectrum of HPV-infected women in Nigeria: an analysis by next-generation sequencing and type-specific PCR

    Background

    Human papillomavirus (HPV) infection and cervical cancer are leading health problems and causes of death in many parts of the world. There...

    Ngozi Dom-Chima, Yakubu Abubakar Ajang, ... Subhasis B. Biswas in Virology Journal
    Article Open access 11 July 2023
  14. Hyperactivation of p53 using CRISPRa kills human papillomavirus-driven cervical cancer cells

    Clinical and pre-clinical work for a number of cancer types has demonstrated relatively positive outcomes and effective tumour regression when the...

    Yusuf M. Idres, Alan J. Lai, ... Adi Idris in Virus Genes
    Article 06 December 2022
  15. Evaluation of human papillomavirus DNA in colorectal cancer and adjacent mucosal tissue samples

    Background

    Although the role of viral agents, such as human papillomavirus (e.g. HPV16, HPV18) in colorectal cancer (CRC) has been previously...

    Luisa Galati, Purnima Gupta, ... Tarik Gheit in Infectious Agents and Cancer
    Article Open access 08 November 2023
  16. Awareness of human papillomavirus infection among Indigenous males in North America and Oceania: a Sco** Review

    Purpose

    Human papillomavirus (HPV) is the most commonly transmitted sexually transmitted infection. HPV infections have been on the rise among males,...

    Simran Bedi, Robert Strachan, Ingeborg Zehbe in Cancer Causes & Control
    Article 13 October 2023
  17. Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening

    Vaccination against human papillomavirus (HPV) is changing the performance of cytology as a cervical screening test, but its effect on HPV testing is...

    Matejka Rebolj, Adam R. Brentnall, Kate Cuschieri in British Journal of Cancer
    Article Open access 13 April 2024
  18. Human papillomavirus prevalence and genotype distribution landscapes in Shannan City, Tibet Tibetan Autonomous Region, China

    Background

    Data regarding human papillomavirus (HPV) prevalence and genotype distribution are limited in Shannan City, Tibet Tibetan Autonomous...

    Dilu Feng, Sitian Wei, ... **aowu Zhu in Virology Journal
    Article Open access 18 March 2022
  19. An Interactive Educational Tool to Improve Human Papillomavirus Vaccine Knowledge and Recommendation Among Nurses

    In United States, only 57% of  women and 53% of men in the recommended age groups have received all recommended doses of the human papillomavirus...

    Shuk On Annie Leung, Alessandro Villa, ... Sarah Feldman in Journal of Cancer Education
    Article 23 August 2023
  20. The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)

    Cervical cancer (CC) and other malignant malignancies are acknowledged to be primarily caused by persistent human papillomavirus (HPV) infection....

    Fatemeh Movahed, Satinik Darzi, ... Omid Gholizadeh in Virology Journal
    Article Open access 31 May 2024
Did you find what you were looking for? Share feedback.